Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030580067> ?p ?o ?g. }
- W2030580067 endingPage "716" @default.
- W2030580067 startingPage "708" @default.
- W2030580067 abstract "BACKGROUND Focal carcinoma detected by needle biopsy has been a common finding since prostate-specific antigen (PSA)-based screening was introduced. Clinicopathologic features in patients with focal prostate carcinoma who underwent radical prostatectomy (RP) or who were treated with watchful waiting (WW) were analyzed to detect clinical predictors for disease progression during follow-up. METHODS Patients were selected from the European Randomized Screening study for Prostate Cancer. Focal carcinoma on sextant biopsy was defined as ≤ 3.0 mm involvement by tumor in 1 biopsy core lacking Gleason pattern 4 or 5. PSA doubling time was used in the WW group as a marker of disease progression. RESULTS The proportion of patients with focal prostate carcinoma increased significantly from 16% in the first screening round to 29% in the second screening round. One hundred eighteen men underwent RP, and 108 men were treated with WW. The median tumor volume was 0.13 mL. PSA level and prostate volume were predictive for tumor volume in a multivariate regression analysis. A PSA density cut-off level of ≤ 0.1 ng/mL/cm3 predicted organ-confined tumor (< 0.5 mL) in 94% of patients. Positive surgical margins were predictive for PSA recurrence. Four patients in the RP group had PSA recurrence at follow-up. PSA doubling times < 2 years, < 3 years, and < 4 years were noted in 4.9%, 14.6%, and 22.0% of patients in the WW group, respectively. CONCLUSIONS The median tumor volume was small (0.13 mL). A comparison between PSA recurrence in the RP group and PSA doubling time in the WW group showed a significantly more favorable outcome after RP if a PSA doubling time of < 3 years or < 4 years was chosen as a marker for disease progression in the WW group. A WW policy with delayed curative intent may be recommended in patients ages 55–75 years with focal carcinoma and PSA density < 0.1 ng/mL/cm3. Cancer 2005. © 2005 American Cancer Society." @default.
- W2030580067 created "2016-06-24" @default.
- W2030580067 creator A5000287380 @default.
- W2030580067 creator A5039867286 @default.
- W2030580067 creator A5041240078 @default.
- W2030580067 creator A5041265748 @default.
- W2030580067 creator A5044653994 @default.
- W2030580067 creator A5057500759 @default.
- W2030580067 date "2005-01-12" @default.
- W2030580067 modified "2023-10-17" @default.
- W2030580067 title "Incidence and follow-up of patients with focal prostate carcinoma in 2 screening rounds after an interval of 4 years" @default.
- W2030580067 cites W1602530656 @default.
- W2030580067 cites W190857994 @default.
- W2030580067 cites W1970275235 @default.
- W2030580067 cites W1980245127 @default.
- W2030580067 cites W1981604066 @default.
- W2030580067 cites W2005998463 @default.
- W2030580067 cites W2026648444 @default.
- W2030580067 cites W2035809577 @default.
- W2030580067 cites W2035828101 @default.
- W2030580067 cites W2037258013 @default.
- W2030580067 cites W2040411631 @default.
- W2030580067 cites W2040559387 @default.
- W2030580067 cites W2047283411 @default.
- W2030580067 cites W2057469006 @default.
- W2030580067 cites W2058515484 @default.
- W2030580067 cites W2059487933 @default.
- W2030580067 cites W2065284940 @default.
- W2030580067 cites W2082505081 @default.
- W2030580067 cites W2085878541 @default.
- W2030580067 cites W2093083902 @default.
- W2030580067 cites W2095445452 @default.
- W2030580067 cites W2096389968 @default.
- W2030580067 cites W2113999232 @default.
- W2030580067 cites W2121103668 @default.
- W2030580067 cites W2122119582 @default.
- W2030580067 cites W2132985516 @default.
- W2030580067 cites W2142775721 @default.
- W2030580067 cites W2166662191 @default.
- W2030580067 doi "https://doi.org/10.1002/cncr.20840" @default.
- W2030580067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15648082" @default.
- W2030580067 hasPublicationYear "2005" @default.
- W2030580067 type Work @default.
- W2030580067 sameAs 2030580067 @default.
- W2030580067 citedByCount "33" @default.
- W2030580067 countsByYear W20305800672012 @default.
- W2030580067 countsByYear W20305800672013 @default.
- W2030580067 countsByYear W20305800672016 @default.
- W2030580067 countsByYear W20305800672018 @default.
- W2030580067 countsByYear W20305800672021 @default.
- W2030580067 crossrefType "journal-article" @default.
- W2030580067 hasAuthorship W2030580067A5000287380 @default.
- W2030580067 hasAuthorship W2030580067A5039867286 @default.
- W2030580067 hasAuthorship W2030580067A5041240078 @default.
- W2030580067 hasAuthorship W2030580067A5041265748 @default.
- W2030580067 hasAuthorship W2030580067A5044653994 @default.
- W2030580067 hasAuthorship W2030580067A5057500759 @default.
- W2030580067 hasConcept C120665830 @default.
- W2030580067 hasConcept C121332964 @default.
- W2030580067 hasConcept C121608353 @default.
- W2030580067 hasConcept C126322002 @default.
- W2030580067 hasConcept C126894567 @default.
- W2030580067 hasConcept C141071460 @default.
- W2030580067 hasConcept C2775934546 @default.
- W2030580067 hasConcept C2776141087 @default.
- W2030580067 hasConcept C2776235491 @default.
- W2030580067 hasConcept C2777546739 @default.
- W2030580067 hasConcept C2779466945 @default.
- W2030580067 hasConcept C2780192828 @default.
- W2030580067 hasConcept C2781406297 @default.
- W2030580067 hasConcept C61511704 @default.
- W2030580067 hasConcept C71924100 @default.
- W2030580067 hasConceptScore W2030580067C120665830 @default.
- W2030580067 hasConceptScore W2030580067C121332964 @default.
- W2030580067 hasConceptScore W2030580067C121608353 @default.
- W2030580067 hasConceptScore W2030580067C126322002 @default.
- W2030580067 hasConceptScore W2030580067C126894567 @default.
- W2030580067 hasConceptScore W2030580067C141071460 @default.
- W2030580067 hasConceptScore W2030580067C2775934546 @default.
- W2030580067 hasConceptScore W2030580067C2776141087 @default.
- W2030580067 hasConceptScore W2030580067C2776235491 @default.
- W2030580067 hasConceptScore W2030580067C2777546739 @default.
- W2030580067 hasConceptScore W2030580067C2779466945 @default.
- W2030580067 hasConceptScore W2030580067C2780192828 @default.
- W2030580067 hasConceptScore W2030580067C2781406297 @default.
- W2030580067 hasConceptScore W2030580067C61511704 @default.
- W2030580067 hasConceptScore W2030580067C71924100 @default.
- W2030580067 hasFunder F4320320300 @default.
- W2030580067 hasFunder F4320322777 @default.
- W2030580067 hasIssue "4" @default.
- W2030580067 hasLocation W20305800671 @default.
- W2030580067 hasLocation W20305800672 @default.
- W2030580067 hasOpenAccess W2030580067 @default.
- W2030580067 hasPrimaryLocation W20305800671 @default.
- W2030580067 hasRelatedWork W1888477076 @default.
- W2030580067 hasRelatedWork W1968225217 @default.
- W2030580067 hasRelatedWork W2075763133 @default.
- W2030580067 hasRelatedWork W2080096858 @default.